June 2023 Br J Cardiol 2023;30:70–3 doi:10.5837/bjc.2023.017
Gustavo A Giunta, Pablo D Cutine, María F Aguiló Iztueta, Daniel Pirola, Nahuel Messina, Lorena Helman, María I Rodríguez Acuña, Ariel Kraselnik, Laura Brandani, Juan J Badimon
Introduction Overweight and obesity are a global pandemic.1 These evermore frequent conditions are associated with serious chronic diseases (e.g. diabetes mellitus, hyperlipidaemia, cancer), and incremented risk for cardiovascular events.2,3 Metabolic syndrome (MS), a constellation of anthropometric and metabolic anomalies, is frequently associated with an increased body mass index (BMI) and related to an adverse cardiovascular prognosis.4 Despite the well-established association between BMI and cardiovascular prognosis, the concept of healthy obesity has emerged in more recent years, resembling a phenotype of obesity without metabolic distur
July 2010 Br J Cardiol 2010;17:163-5
BJ Cardio Staff
The study, published in the May 25, 2010 issue of the Journal of the American College of Cardiology, analysed data from the INTERHEART study, a case control study of incident acute MI, to investigate whether the risk of MI associated with the metabolic syndrome is greater than that conferred by its constituent components (such as abdominal obesity, elevated glucose, abnormal lipids, and elevated blood pressure).Results showed that metabolic syndrome was associated with a two- to three-times increased risk of MI, but the same risk was conferred by having either hypertension or diabetes alone. The authors explain that supporters of the metabo
March 2006 Br J Cardiol 2006;13:113-20
Colin Waine
No content available
July 2005 Br J Cardiol 2005;12:249-53
Michael EJ Lean, Thang S Han
No content available
March 2003 Br J Cardiol 2003;10:128-36
Clifford J Bailey, Caroline Day
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits